Additionally, type 2 diabetes mellitus-related polymorphisms and single-nucleotide polymorphisms (SNPs) in genes regulating insulin signaling and inflammatory pathways may interact with these mutations, further elevating cancer susceptibility. This evidence concerns the gene INS and cancer.